Tracy William, Ferrell Brandon E, Skendelas John P, Uehara Mayuko, Sugiura Tadahisa
Department of General Surgery, NYC Health + Hospitals/Metropolitan, New York, NY 10029, USA.
Department of Cardiothoracic and Vascular Surgery, Montefiore Medical Center, Bronx, NY 10467, USA.
J Cardiovasc Dev Dis. 2024 Dec 31;12(1):12. doi: 10.3390/jcdd12010012.
The use of extracorporeal membrane oxygenation (ECMO) has emerged as a rescue intervention for hemodynamically unstable patients and prophylactic intraprocedural hemodynamic support in the cardiac catheterization laboratory. The prompt initiation of ECMO provides immediate hemodynamic support and allows for the completion of bridging and/or life-saving interventions. However, there are no clinical practice guidelines for the use of extracorporeal support in this area. This review examines the role of patient selection and therapeutic intervention for extracorporeal support in the cardiac catheterization laboratory.
体外膜肺氧合(ECMO)的应用已成为对血流动力学不稳定患者的一种抢救干预措施,以及在心脏导管实验室中进行预防性术中血流动力学支持的手段。ECMO的迅速启动可提供即时的血流动力学支持,并有助于完成桥接和/或挽救生命的干预措施。然而,在这一领域尚无关于使用体外支持的临床实践指南。本综述探讨了在心脏导管实验室中患者选择及体外支持治疗干预的作用。